These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 32115493)
1. CD44 Genotypes Are Associated with Susceptibility and Tumor Characteristics in Colorectal Cancer Patients. Márquez-González RM; Saucedo-Sariñana AM; Barros-Núñez P; Gallegos-Arreola MP; Pineda-Razo TD; Marin-Contreras ME; Flores-Martínez SE; Sánchez-Corona J; Rosales-Reynoso MA Tohoku J Exp Med; 2020 Feb; 250(2):109-119. PubMed ID: 32115493 [TBL] [Abstract][Full Text] [Related]
2. Genetic Polymorphisms in APC, DVL2, and AXIN1 Are Associated with Susceptibility, Advanced TNM Stage or Tumor Location in Colorectal Cancer. Rosales-Reynoso MA; Saucedo-Sariñana AM; Contreras-Díaz KB; Márquez-González RM; Barros-Núñez P; Pineda-Razo TD; Marin-Contreras ME; Durán-Anguiano Ó; Gallegos-Arreola MP; Flores-Martínez SE; Sánchez-Corona J Tohoku J Exp Med; 2019 Nov; 249(3):173-183. PubMed ID: 31723073 [TBL] [Abstract][Full Text] [Related]
3. GSK3β Polymorphisms Are Associated with Tumor Site and TNM Stage in Colorectal Cancer. Rosales-Reynoso MA; Zepeda-López P; Saucedo-Sariñana AM; Pineda-Razo TD; Barros-Núñez P; Gallegos-Arreola MP; Flores-Martínez SE; Sánchez-Corona J Arch Iran Med; 2019 Aug; 22(8):453-460. PubMed ID: 31679348 [TBL] [Abstract][Full Text] [Related]
4. Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma. Winder T; Ning Y; Yang D; Zhang W; Power DG; Bohanes P; Gerger A; Wilson PM; Lurje G; Tang LH; Shah M; Lenz HJ Int J Cancer; 2011 Sep; 129(5):1096-104. PubMed ID: 21105049 [TBL] [Abstract][Full Text] [Related]
5. Association of Two CD44 Polymorphisms with Clinical Outcomes of Gastric Cancer Patients. Bitaraf SM; Mahmoudian RA; Abbaszadegan M; Mohseni Meybodi A; Taghehchian N; Mansouri A; Forghanifard MM; Memar B; Gholamin M Asian Pac J Cancer Prev; 2018 May; 19(5):1313-1318. PubMed ID: 29802692 [TBL] [Abstract][Full Text] [Related]
6. RECK Variants are Associated with Clinicopathological Features and Decreased Susceptibility in Mexican Patients with Colorectal Cancer. María Márquez-González R; Margarita Saucedo-Sariñana A; Barros-Núñez P; Patricia Gallegos-Arreola M; Ibet Juárez-Vázquez C; Daniel Pineda-Razo T; Eugenia Marin-Contreras M; Esperanza Flores-Martínez S; Alejandra Rosales-Reynoso M Tohoku J Exp Med; 2022 Jun; 257(2):163-169. PubMed ID: 35444107 [TBL] [Abstract][Full Text] [Related]
7. NME1 and DCC variants are associated with susceptibility and tumor characteristics in Mexican patients with colorectal cancer. Márquez-González RM; Saucedo-Sariñana AM; de Jesús Tovar-Jacome C; Barros-Núñez P; Gallegos-Arreola MP; Orozco-Gutiérrez MH; Mariscal-Ramírez I; Pineda-Razo TD; Alcaraz-Wong AA; Marín-Contreras ME; Rosales-Reynoso MA J Egypt Natl Canc Inst; 2024 Apr; 36(1):10. PubMed ID: 38556604 [TBL] [Abstract][Full Text] [Related]
8. Cancer Stem Cell Gene Variants in CD44 Predict Outcome in Stage II and Stage III Colon Cancer Patients. Stotz M; Herzog SA; Pichler M; Smolle M; Riedl J; Rossmann C; Bezan A; Stöger H; Renner W; Berghold A; Gerger A Anticancer Res; 2017 Apr; 37(4):2011-2018. PubMed ID: 28373475 [TBL] [Abstract][Full Text] [Related]
9. Association of single nucleotide polymorphisms in the coding region of Bcl-2 with the occurrence and prognosis of colorectal cancer: A case-control study. Huang B; Liu X; Sun C; Wang L; Yang L Cancer Biomark; 2017; 18(4):433-439. PubMed ID: 28106544 [TBL] [Abstract][Full Text] [Related]
10. Gene Combination of CD44 rs187116, CD133 rs2240688, NF-κB1 rs28362491 and GSTM1 Deletion as a Potential Biomarker in Risk Prediction of Breast Cancer in Lower Northern Thailand. Sapcharoen K; Sanguansermsri P; Yasothornsrikul S; Muisuk K; Srikummool M Asian Pac J Cancer Prev; 2019 Aug; 20(8):2493-2502. PubMed ID: 31450925 [TBL] [Abstract][Full Text] [Related]
11. TCF7L2 and CCND1 polymorphisms and its association with colorectal cancer in Mexican patients. Rosales-Reynoso MA; Arredondo-Valdez AR; Juárez-Vázquez CI; Wence-Chavez LI; Barros-Núñez P; Gallegos-Arreola MP; Flores-Martínez SE; Morán-Moguel MC; Sánchez-Corona J Cell Mol Biol (Noisy-le-grand); 2016 Sep; 62(11):13-20. PubMed ID: 27755946 [TBL] [Abstract][Full Text] [Related]
12. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study. Banday MZ; Sameer AS Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064 [No Abstract] [Full Text] [Related]
13. Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotypes to Colorectal Cancer Risk in Taiwan. Chang WS; Yueh TC; Tsai CW; Ji HX; Wu CN; Wang SC; Lai YL; Hsu SW; Hsieh MH; Hsiao CL; Hung YW; Shih TC; Bau DT Anticancer Res; 2016 Apr; 36(4):1657-63. PubMed ID: 27069143 [TBL] [Abstract][Full Text] [Related]
14. Molecular evaluation of glutathione S transferase family genes in patients with sporadic colorectal cancer. Rodrigues-Fleming GH; Fernandes GMM; Russo A; Biselli-Chicote PM; Netinho JG; Pavarino ÉC; Goloni-Bertollo EM World J Gastroenterol; 2018 Oct; 24(39):4462-4471. PubMed ID: 30356976 [TBL] [Abstract][Full Text] [Related]
15. Association of heparanase gene (HPSE-1) single nucleotide polymorphisms with gastric cancer. Yue Z; Song Y; Wang Z; Luo Y; Jiang L; Xing L; Xu H; Zhang X J Surg Oncol; 2010 Jul; 102(1):68-72. PubMed ID: 20578081 [TBL] [Abstract][Full Text] [Related]
16. Strong association of interleukin-6 -174G/C promoter single nucleotide polymorphism with a decreased risk of colorectal cancer in ethnic Kashmiri population: A case control study. Banday MZ; Balkhi HM; Sameer AS; Chowdri NA; Haq E Tumour Biol; 2017 Mar; 39(3):1010428317695940. PubMed ID: 28349833 [TBL] [Abstract][Full Text] [Related]
17. CD44 single nucleotide polymorphism and isoform switching may predict gastric cancer recurrence. Suenaga M; Yamada S; Fuchs BC; Fujii T; Kanda M; Tanaka C; Kobayashi D; Fujiwara M; Tanabe KK; Kodera Y J Surg Oncol; 2015 Nov; 112(6):622-8. PubMed ID: 26416034 [TBL] [Abstract][Full Text] [Related]
18. Vitamin D receptor gene polymorphism(s) and breast cancer risk in north Indians. Chakraborty A; Mishra AK; Soni A; Regina T; Mohil R; Bhatnagar D; Bhatnagar A; Chintamani C; Sharma PC; Saxena S Cancer Detect Prev; 2009; 32(5-6):386-94. PubMed ID: 19588543 [TBL] [Abstract][Full Text] [Related]
19. Association of CD44 gene rs187115 polymorphism with colorectal cancer risk and prognosis in Chinese Han population: a case-control study. Wan Q; Zhang D; Zhou Q; Li M; Wang Y; Song Y; Xu T Aging (Albany NY); 2019 Nov; 11(21):9616-9625. PubMed ID: 31682231 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic value of CD44 gene polymorphism (rs187115) in Swedish patients with colorectal cancer. Nguyen SV; Shamoun L; Landerholm K; Wågsäter D; Dimberg J Nucleosides Nucleotides Nucleic Acids; 2023; 42(10):807-817. PubMed ID: 37074032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]